Ocular irritancy
This article was originally published in The Rose Sheet
Executive Summary
National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods issues second request for data on chemicals evaluated in in vitro or in vivo ocular irritancy test methods in Feb. 28 1Federal Register notice. Agency is preparing final background documents on four in vitro test methods for assessing ocular irritation in collaboration with Interagency Coordinating Committee on the Validation of Alternative Methods and the European Center for the Validation of Alternative Methods. Data will be used to develop a list of substances with high quality in vivo data that can be considered as reference chemicals for future validation studies. Initial data request was made in March and was used to prepare draft background review documents for four in vitro assays, addressed by an ICCVAM panel in January (2"The Rose Sheet" Jan. 17, 2005, p. 4). Data should be submitted to NICEATM by March 30...
You may also be interested in...
Ocular Irritation Assay Data Deemed Incomplete By ICCVAM Panel
Existing data are inadequate to determine whether the Isolated Rabbit Eye test method can identify severe ocular irritants or corrosives under a tiered testing strategy, the Interagency Coordinating Committee on the Validation of Alternative Methods expert panel concluded during a Jan. 11-12 meeting in Bethesda, Md
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.